Bone metabolism, bone density and estrogen levels in perimenopause: A prospective 2-year-study;Knochenstoffwechsel, knochendichte und östrogenspiegel in der perimenopause: Eine prospektive 2-jahres-untersuchung

Zentralblatt fur Gynakologie

Volumn 127, Issue 3, 2005, Pages 132-139

  Seifert Klauss, Vanadin ^a   Laakmann, J ^a   Rattenhuber, J ^a   Hoss C ^a   Luppa, P ^b   Kiechle, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bone density; Bone metabolism; Estrogen; Menopause; Perimenopause

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; ESTROGEN; OSTEOCALCIN; PYRIDINOLINE; ALKALINE PHOSPHATASE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE;

ADULT; ANOVULATION; ARTICLE; BONE DENSITY; BONE METABOLISM; CLIMACTERIUM; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDY; TRABECULAR BONE; URINALYSIS; BLOOD; BONE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; ESTRADIOL; ESTROGENS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MIDDLE AGED; OSTEOCALCIN; PERIMENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE;

EID: 20444474985     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-836439     Document Type: Article

References (28)

1. Bartl R. Osteoporose - Prävention, Diagnostik, Therapie. Thieme Stuttgart, New York 2001
2. Blumsohn A, Eastell R. The performance and utility of biochemical bone markers of bone turnover: do we know enough to use them in practice? Ann Clin Biochem 1997; 34: 449-459
3. Bowman BM, Miller SC. Elevated progesterone during pseudopregnancy may prevent bone loss associated with low estrogen. J Bone Miner Res 1996; 11:15-21
4. Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in menopausal transition. Recent Prog Horm Res 2002; 57: 257-275
5. Calvo M, Eyre D, Grundberg C. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 1996; 17: 333-359
6. Eastell R, Robins SP, Colwell T, Assiri AMA, Riggs BL, Russell RGG. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporos Int 1993; 3: 255-260
7. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, Wark JD. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996; 81: 3366-3371
8. Feige A. Klimakterium. In: Feige A, Rempen A, Würfel W, Jawny J, Caffier H. Frauenheilkunde - Fortpflanzungsmedizin, Geburtsmedizin, Onkologie. 2. Auflage. Urban & Fischer, München, Jena 2001; 235-274
9. Gallagher JC. Role of estrogens in the management of postmenopasual bone loss. Rheum Dis Clin North Am 2001; 27: 143-162
10. Garnero P, Delmas PD. Biochemical markers of bone turnover - applications for osteoporosis. Endocrinol Metab Clin North Am 1998; 27: 303-323
11. Garnero P, Borel O, Delmas PD. Evaluation of a fully automated serum assay for C-terminal cross-linking Telopeptide of type I collagen in osteoporosis. Clin Chem 2001; 47: 694-702
12. Gorai I, Taguchi Y, Chaki O, Nakayama M, Minaguchi H. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover. Calcif Tissue Int 1997; 60: 317-322
13. Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomised clinical trial. J Bone Miner Res 1998; 13: 1431-1438
14. Guthrie JR, Ebeling PR, Hopper JL, Barrett-Connor E, Dennerstein L, Dudley EC, Burger HG, Wark JD. A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int 1998; 8: 282-290
15. Hoshino H, Kushida K, Takahashi M, Yamazaki K, Denda M, Atsumo K, Oikawa M, Toyoyama O, Kawana K, Inoue T. Changes in levels of biochemical markers and ultrasound indices of os calcis across the menopausal transition. Osteoporos Int 2000; 11: 128-133
16. Kawana K, Kushida K, Takahashi T, Ohishi T, Denda M, Yamazaki K, Inoue T. The effect of menopause on biochemical markers and ultrasound densitometry in healthy females. Calcif Tissue Int 1994; 55: 420-425
17. Marcus R, Holloway L, Wells B, Greendale G, James M, Wasilauskas C, Kelaghan J. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: Results from the postmenopausal estrogen/progestin interventions (PEPI) trial. J Bone Miner Res 1999; 14: 1583-1595
18. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. End Rev 2000; 21: 115-137
19. Prior JC, Vigna YM, Barr SI, Rexworthy C, Lentle BC. Cyclic medroxy-progesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances. Am J Med 1994; 96: 521-530
20. Prior JC Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 1998; 19: 397-428
21. Randolph Jr JF, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Mathews KA, Sternfeld B, Lasley BL Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 2003; 88: 1516-1522
22. Ranenevik G, Jeppson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995; 21: 103-113
23. Reyes FI, Winter JS, Faiman C. Pituitary-ovarian relationships preceding the menopause I. A cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol and progesterone levels. Am J Obstet Gynecol 1977; 129: 557-564
24. Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocrine Rev 2002; 23: 279-302
25. Seibel MJ, Lang M, Geilenkeuser WJ. Interlaboratory variation of biochemical markers of bone turnover. Clin Chem 2001; 47: 1443-1450
26. Seifert-Klauss V, Müller JE, Luppa P, Probst R, Wilker J, Höss C, Treumann T, Kastner C, Ulm K. Bone metabolism during the perimenopausal transition: a prospective study. Maturitas 2002; 41: 23-33
27. The Writing Group for the PEPI trial. Effects of hormone therapy on bone mineral density - results from the postmenopausal estrogen/ progestin interventions (PEPI) trial. JAMA 1996; 276: 1389-1396
28. Woitge HW, Seibel MJ. Biochemical markers to survey bone turnover. Rheum Dis Clin North Am 2001; 27: 49-80